02 Apr, EOD - Indian

Nifty Pharma 21808.4 (-0.92)

Nifty IT 30441.45 (2.60)

Nifty 50 22713.1 (0.15)

Nifty Bank 51548.75 (0.19)

Nifty Smallcap 100 15650.5 (-0.38)

Nifty Next 50 61957.6 (0.07)

Nifty Midcap 100 53677.05 (-0.26)

SENSEX 73319.55 (0.25)

02 Apr, EOD - Global

NIKKEI 225 53123.49 (1.26)

HANG SENG 25116.53 (-0.70)

S&P 6603.69 (0.11)


Mid Session News

You are Here : Home > News > Mid Session News >

(18 Dec 2025, 12:32)

Nifty above 25,850; IT shares advance


The key equity benchmarks continued to trade with modest gains in the early afternoon trade. The Nifty traded above the 25,850 mark. IT shares extended gains for the second consecutive trading session.

At 12:30 ST, the barometer index, the S&P BSE Sensex, rose 124.10 points or 0.15% to 84,683.75. The Nifty 50 index added 65.45 points or 0.25% to 25,879.50.

In the broader market, the S&P BSE Mid-Cap index rose 0.12% and the S&P BSE Small-Cap index fell 0.21%.

The market breadth was negative. On the BSE, 1,645 shares rose and 2,281 shares fell. A total of 180 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, fell 1.37% to 9.70. The Nifty 30 December 2025 futures were trading at 25,953.10, at a premium of 73.6 points as compared with the spot at 25,879.50.

The Nifty option chain for the 30 December 2025 expiry showed a maximum call OI of 83.8 lakh contracts at the 26,000 strike price. Maximum put OI of 77.1 lakh contracts was seen at the 26,000 strike price.

Buzzing Index:

The Nifty IT index rose 0.99% to 38,548.15. The index added 1.28% in the two consecutive trading sessions.

Infosys (up 1.33%), Tata Consultancy Services (up 1.31%), Mphasis (up 1.04%), Wipro (up 0.98%), Persistent Systems (up 0.72%), Tech Mahindra (up 0.7%), HCL Technologies (up 0.3%) and Coforge (up 0.29%) rose.

Stocks in Spotlight:

Patel Engineering surged 1.75% after it signed a memorandum of understanding (MoU) with the Government of Arunachal Pradesh for the restoration and development of the 144 MW Gongri Hydropower Project in West Kameng District.

Sun Pharmaceutical Industries declined 2.96% after the company announced that the US FDA, post an audit, has determined the Baska facility inspection classification as Official Action Indicated (OAI).

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +